 |
Antisense oligonucleotide directed against TGF-beta2 mRNA |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of scarring post glaucoma filtration surgery |
| EU Market Approval | EU |
| EU Designation Date | 2015-06-19 00:00:00 |
| Sponsor | Isarna Therapeutics GmbH |
| |
Antisense oligonucleotide directed against TGF-beta2 mRNA |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of scarring post glaucoma filtration surgery |
| EU Market Approval | EU |
| EU Designation Date | 2015-06-19 00:00:00 |
| Sponsor | Isarna Therapeutics GmbH |